Board Moves.

AdaptHealth (NASDAQ: AHCO)

Appoints Diana Nole to the Board of Directors. Ms. Nole is the former CVP Microsoft Health & Life Sciences | EVP and GM, Nuance Healthcare Division at Microsoft.

Artiva Biotherapeutics (NASDAQ: ARTV)

Appoints Alison Moore to the Board of Directors. Ms. Moore is the Chief Technical Officer at Codexis.

BrightSpring Health Srvs (NASDAQ: BTSG)

Appoints Steve Miller to the Board of Directors. Mr. Miller is the Chief Medical Officer at MediBeacon.

DocGo (NASDAQ: DCGO)

Appoints Stephen Klasko to the Board of Directors. Mr. Klasko is the Chief Medical Officer at Abundant Venture Partners.

Grail (NASDAQ: GRAL)

Appoints Sarah Krevans to the Board of Directors. Ms. Krevans is the former Chief Executive Officer at Sutter Health.

Guardant Health (NASDAQ: GH)

Appoints Roberto Mignone to the Board of Directors. Mr. Mignone is a Founding Managing Partner at Bridger Management.

Humana (NYSE: HUM)

Appoints Gordon Smith to the Board of Directors. Mr. Smith is the former COO at JPMorgan Chase.

Kiniksa Pharmaceuticals (NASDAQ: KNSA)

Appoints Cantey Boyd to the Board of Directors. Mr. Boyd is the Managing Director at Baker Brothers Advisors.

Kyverna Therapeutics (NASDAQ: KYTX)

Appoints Mert Aktar to the Board of Directors. Mr. Aktar is the Chief Executive Officer at Receptive Bio.

LivaNova (NASDAQ: LIVN)

Appoints Susan Podlogar to the Board of DIrectors. Ms. Podlogar is the former Chief Human Resource Officer at MetLife.

Masimo (NASDAQ: MASI)

Appoints Timothy Scannell and Wendy Lane to the Board of Directors. Mr.Scannell is the former Chief Operating Officer at Stryker and Ms. Lane is the former Managing Director at DLJ.

MaxCyte (NASDAQ: MXCT)

Appoints Cynthia Collins to the Board of Directors. Ms. Collins is th e former Chief Executive Officer at Editas Medicine.

Moderna (NASDAQ: MRNA)

Appoints Abbas Hussain to the Board of Directors. Mr. Hussain is the former Chief Executive Officer at Vifor Pharma.

Neogen (NASDAQ: NEOG)

Appoints Thierry Bernard to the Board of Directors. Mr. Bernard is the Chief Executive Officer at Qiagen.

Nurix Therapeutics (NASDAQ: NRIX)

Appoints Anil Kapur to the Board of Directors. Mr. Kapur is the former Strategy & Chief Commercial Officer at Geron.

Pfizer (NYSE: PFE)

Appoints Mortimer Buckley to the Board of Directors. Mr. Buckley is the former Chair of the Board and Chief Executive Officer at Vanguard.

Sanara Medtech (NASDAQ: SMTI)

Appoints Keith Myers to the Board of Directors. Mr. Myers is the CoFounder at LHC Group.

‍

‍

MacroGenics (NASDAQ: MGNX)

Scott Koenig departs as CEO and from the Board of Directors.

Trevi Therapeutics (NASDAQ: TRVI)

James Cassella resigns from the Board of Directors. Mr. Cassella is the Chief Development Officer at Trevi Therapeutics.

Tyra Biosciences (NASDAQ: TYRA)

Sid Subramony resigns from the Board of Directors. Mr. Subramony is a VP at Boxer Capital.

Verrica Pharmaceuticals (NASDAQ: VRCA)

Craig Ballaron resigns from the Board of Directors. Mr. Ballaron is the former Co-Founder at Aqua Pharmaceuticals Holdings, Inc.

Warby Parker (NYSE: WRBY)

Gabrielle Sulzberger resigns from the Board of Directors. Ms. Sulzberger is the former Co-Founder and Partner at Fontis Partners.

Xencor (NASDAQ: XNCR)

Dagmar Rosa-Bjorkeson to leave the Board of Directors. Ms. RosaBjorkeson is the Chief Operating Officer at Mesoblast Ltd.

Zymeworks (NASDAQ: ZYME)

Hollings Renton resigns from the Board of Directors. Mr. Renton is the former Chief Executive Officer at Onyx Pharmaceuticals.